Immucell ICCC
NASDAQ ICCC
$11.42 +0.67 (+6.23%)
At close: Nov 16, 2026 · 4:00 PM EST

Immucell (ICCC) Income from Continuing Operations (2009 - 2026)

Updated

Immucell (ICCC) recorded Income from Continuing Operations of $952,510 in Q3 2026, compared with -$139,748 a year earlier and down 48.1% from the prior quarter.

Analysis

Immucell (ICCC) Income from Continuing Operations (2009 - 2026) Analysis & Trends

On a TTM basis, Immucell's Income from Continuing Operations came in at $1.88 million as of Sep 30, 2026, down 19.1% year-over-year; for FY2025, it came in at -$1.04 million.

  • Across earlier years, Income from Continuing Operations came in at -$2.16 million in FY2024, -$5.77 million in FY2023, -$2.49 million in FY2022 and -$78,292 in FY2021.
  • Quarterly Income from Continuing Operations has ranged from -$2.85 million in Q4 2025 to $1.94 million in Q1 2026 over the past five years.
  • Per Business Quant, the preceding three quarters came in at $1.83 million (Q2 2026), $1.94 million (Q1 2026) and -$2.85 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 6.45 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 210.00 Mn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 4.22 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 5.07 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 4.80 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 3.86 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 2.43 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 3.25 Bn
10 Immucell 102.43 Mn 75.03 Mn 3.56 Mn 952,510.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 952,510.00
Jun 30, 2026 1.83 Mn
Mar 31, 2026 1.94 Mn
Dec 31, 2025 -2.85 Mn
Sep 30, 2025 -139,748.00
Jun 30, 2025 501,880.00
Mar 31, 2025 1.45 Mn
Dec 31, 2024 514,555.00
Sep 30, 2024 -701,690.00
Jun 30, 2024 -1.53 Mn
Mar 31, 2024 -437,868.00
Dec 31, 2023 -1.14 Mn
Sep 30, 2023 -940,000.00
Jun 30, 2023 -1.38 Mn
Mar 31, 2023 -2.32 Mn
Dec 31, 2022 -1.67 Mn
Sep 30, 2022 -655,078.00
Jun 30, 2022 -684,148.00
Mar 31, 2022 513,287.00
Dec 31, 2021 74,134.00
API Access

Immucell Income from Continuing Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=ICCC&period=max&api_key=YOUR_API_KEY